Marijuana is the most commonly used federally illegal drug in America, according to the Center for Disease Control and Prevention. It is especially popular among young people aged 18-25, many of whom believe it does not pose a health risk. Those beliefs are fortified by the legalization of both medicinal and recreational marijuana in a growing number of states. However, marijuana use can have serious, long-term negative effects on physical and mental health, especially in youth, young adults and women who are pregnant or nursing.
It’s a myth that marijuana is not addictive. Research shows that one in 10 people who use marijuana become addicted. For people who start before the age of 18, that figure rises to 1 in 6.
Research has also shown that people who begin using marijuana regularly at a young age can suffer permanent IQ loss of up to eight points.
Use during pregnancy can affect fetal development in a number of ways, leading to poor cognitive function, hyperactivity and increased risk of stillbirth and premature birth.
Medical marijuana refers to the use of the marijuana plant or its extracts to treat certain medical conditions or symptoms of an illness.
The FDA has approved one cannabis-derived drug product: Epidiolex (cannabidiol), and three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). They have not approved any other products currently on the market from CBD. Meaning those products made from Hemp (which is legal to grow since 2018) in the US that people might buy are not regulated so those manufacturers can put whatever they want in the product and could be unsafe. Especially products labeled as THC free (fda.gov)
The chemicals in marijuana called cannabinoids include THC and CBD. Scientists are researching both these extracts to determine their effectiveness in treating symptoms of illnesses including pain, inflammation, seizures, substance use disorders, and more.
Legalization by StateSee what states have legalized marijuana
Related COCA Programs
Marijuana Diversion
The Marijuana Diversion Program is a partner program with Berks County Magisterial District Judges to provide education to those charged with marijuana possession or paraphernalia.
This highly interactive, one-session program aims to build critical thinking skills in high school students by fostering discussions on marijuana and its potential consequences.
Every school district in Berks County has a SAP program. This program assists students with barriers to learning and provides resources to help address mental health and drug and alcohol problems.
The Council on Chemical Abuse’s (COCA) Position on Legalization of Marijuana for Recreational Use in Pennsylvania.
COCA does not support the legalization of marijuana for recreational use. The potency of marijuana has increased dramatically with current strains of marijuana being significantly more potent than in the past. Contrary to popular belief, people who use marijuana risk developing a substance use disorder. This risk increases with those who begin using marijuana in their adolescence and have easy access to the drug. We believe that the legalization of marijuana will significantly increase the availability of the drug to youth and young adults in our community.
COCA recommends the expansion of Student Assistance Program efforts to require a fully functioning Student Assistance Program team and process in all Pennsylvania elementary, middle, and high schools. This will ensure that students who use marijuana or other substances have access to intervention and treatment services.
COCA recommends enhancing community educational efforts with respect to the use of marijuana and other substance use.
COCA recommends the expansion of substance use preventative services and treatment opportunities particularly for youth and young adults. Such services should be readily available regardless of health insurance coverage or ability to pay.
COCA supports greater research efforts into the effects of marijuana use as it relates to both the individual and the community.
COCA does not oppose the “decriminalization” of marijuana which would reduce penalties for possession of small amounts of marijuana. People charged with this offense should be offered an opportunity to attend an appropriate education and/or intervention program.
COCA does not oppose Pennsylvania’s current statutes for Medical Marijuana.
Regardless of the legal status of marijuana, COCA will continue to provide prevention education to youth, families, and the community regarding substances and substance use disorders as well as assist individuals to access appropriate treatment and recovery support services to address substance use disorders.
